Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
With 52 consecutive years of dividend growth and a dividend yield of over 3.6%, AbbVie Inc. (NYSE: ABBV ) is one of the most notable dividend stocks. The company is widely known for Humira, its treatment for autoimmune diseases such as Crohn's disease, ulcerative colitis and rheumatoid arthritis. During the first quarter, AbbVie's revenue inched up 0.7% year over year to $12.31 billion, surpassing Wall Street estimates by $370 million. Adjusted EPS in the quarter came in at $2.31, beating analyst consensus by $0.05. The company also increased its full-year 2024 adjusted EPS guidance. It expects the metric to range from $11.13 to $11.33, up from its prior range of $10.97 to $11.17. Despite solid results, the stock fell as AbbVie's top-selling drug Humira saw a 36% decline in sales amid competition from cheaper biosimilars. However, AbbVie Inc. bulls believe Skyrizi and Rinvoq could offset the declines from Humira. Earlier this year, AbbVie increased its sales estimates for Skyrizi a
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Direct Relief Announces Appointment of Three Directors to Board [Yahoo! Finance]Yahoo! Finance
- AbbVie Declares Quarterly DividendPR Newswire
- Top 10 Companies Dominating the Global Drug Delivery Systems Market [Yahoo! Finance]Yahoo! Finance
- Cosmetic Surgery and Procedure Devices Market size is set to grow by USD 7.95 billion from 2024-2028, Growing incidence of medical conditions that require cosmetic procedures boost the market, Technavio [Yahoo! Finance]Yahoo! Finance
- MHRA disallows epilepsy drug topiramate use for pregnant patients [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 6/3/24 - Form 25-NSE
- 5/31/24 - Form SD
- 5/17/24 - Form 25-NSE
- ABBV's page on the SEC website